Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the …
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the infection, researchers at The University of Texas Health Science Center at San Antonio and the Wroclaw University of Science and Technology discovered.
SAN ANTONIO (PRWEB) October 18, 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” tha…
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve